[DOI] [PMC free article] [PubMed] [Google Scholar] 60.Lozic M., Stambolija V., Krezic I., Dugandzic A., Zivanovic-Posilovic G., Gojkovic S., Kovacevic J., Vrdoljak L., Mirkovic I., Kokot A., et al
A Phase 2 study published in the New England Journal of Medicine in 2023 (Jastreboff et al.) reported substantial weight loss in participants with obesity
Autoimmune and inflammatory conditions Patients with autoimmune conditions including lupus, rheumatoid arthritis, and Hashimoto thyroiditis have increasing access to GLP-1 therapy, and the anti-inflammatory mechanism provides specific rationale for this use
AHK-Cu, CAS 682809-81-0, also known as Alanine-Histidine-Lysine-Copper, is a synthetic peptide that has garnered significant attention in recent years due to its potential applications in various fields, particularly in dermatology and regenerative medicine